Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome

Abstract excerpt

BACKGROUND: Numerous preclinical studies have supported the theory that enhanced activation of mGluR5 signaling, due to the absence or reduction of the FMR1 protein, contributes to cognitive and behavioral deficits in patients with fragile X syndrome (FXS). However multiple phase 2 controlled trials in patients with FXS have failed to demonstrate efficacy of compounds that negatively modulate mGluR5, including...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Attention Deficit Hyperactivity Disorder
• Share to Genetics and Neurodevelopmental Disorders
• Share to Ubiquitin and proteasome pathways